Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis

Neurology

Volumn 53, Issue 9, 1999, Pages 2087-2092

  Prat, Alexander ^b   Weinrib, L ^c   Becher, B ^c   Poirier, J ^c   Duquette, P ^c   Couture, R ^a   Antel, J P ^c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NONE

Author keywords

CD3+ lymphocytes; Demyelinating disease; Inflammation; Kinin receptor; Neuropeptide

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ RECEPTOR AGONIST; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; BRADYKININ RECEPTOR; CD3 ANTIGEN; MESSENGER RNA;

ARTICLE; CELL FUNCTION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE INDUCTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE; ADULT; CELL MOTION; DEMYELINATING DISEASE; FEMALE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ADULT; ANTIGENS, CD3; BLOTTING, WESTERN; CELL MOVEMENT; DEMYELINATING DISEASES; FEMALE; GENE EXPRESSION; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; POLYMERASE CHAIN REACTION; RECEPTOR, BRADYKININ B1; RECEPTORS, BRADYKININ; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; UP-REGULATION;

EID: 0032585664     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.9.2087     Document Type: Article

References (17)

1. Owens T, Sriram S. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol Clin 1995;13:51-73.
2. Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 1991;20:254-260.
3. Uhm JH, Dooley NP, Stuve O, et al. Migratory behavior of T lymphocytes isolated from MS patients undergoing treatment with β-interferon. Neurology 1997;48:A80. Abstract.
4. Stuve O, Dooley NP, Uhm JH, et al. Interferon β-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 1996;40:853-863.
5. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992; 44:1-80.
6. Hall JM. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther 1992;56:131-190.
7. 2 subtypes. Life Sci 1994;55:735-749.
8. 1 receptors: a review. Immunopharmacology 1995;30:1-26.
9. 9-bradykinin in experimental allergic encephalomyelitis. J Neurol Sci 1988;83:211-217.
10. 1 receptors in the polymorphonuclear leukocyte accumulation induced by IL-1 in vivo in the mouse. J Immunol 1996;156:269-274.
11. 1 receptor for kinins. J Pharmacol Exp Ther 1991;259: 997-1003.
12. 1 receptor related peptides: antagonists. Hypertension 1996;28:833-839.
13. 1 receptors. Immunopharmacology 1996; 33:1-8.
14. Chofflon M, Roth S, Juillard C, et al. Tumor necrosis factor production capacity as a potential useful parameter to monitor disease activity in multiple sclerosis. Eur Cytokine Netw 1997;8:253-257.
15. Rieckmann P, Albrecht M, Kitze B, et al. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 1995;37:82-88.
16. Schratzberger P, Reinisch N, Prodinger WM, et al. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol 1997;158: 3895-3901.
17. Xia M, Leppert D, Hauser SL, et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol 1996; 156:160-167.